ICU Medical Inc. is voluntarily recalling one lot of 0.9% sodium chloride injection, USP 1000 mL, due to a confirmed customer complaint of particulate matter identified as stainless steel within a single flexible container, the Food and Drug Administration announced Friday. The reported incident was identified prior to use and no associated adverse events had been reported to date. Hospitals and distributors should not use but return the recalled product if they have it. Any associated adverse reactions or quality problems may be reported to FDA's MedWatch program.

Related News Articles

Headline
The National Collaborative for Improving the Clinical Learning Environment this week released guidance to help health care system leaders work with clinical…
Headline
The Centers for Medicare & Medicaid Services should continue to work with national standards body X12 to include the new unique device identifier on its…
Headline
The Centers for Disease Control and Prevention today issued recommendations to help health care providers and laboratories prevent the spread of Candida auris…
Headline
Inpatient rehabilitation facilities and long-term care hospitals have until Sept. 30 to review their 2016 quality data before it is publicly reported on the…
Headline
The Institute for Safe Medication Practices yesterday released a tool to help hospitals and outpatient facilities evaluate their safety practices for “…
Headline
The Centers for Medicare & Medicaid Services seeks comments through Nov. 20 on a “new direction” for its Innovation Center that will approach…